Previously, we have reported that neutralization of surface lymphotoxin (LT-αβ) in mice which expressed an LT-β receptor-Fc fusion protein, driven by the cytomegalovirus promoter, resulted in an array of anatomic abnormalities. We now report that mice which express a tumor necrosis factor (TNF) receptor p60-Fc fusion protein (which neutralizes TNF and soluble LT-α3 activity) develop unique lymphoid abnormalities. Our data demonstrate that some aspects of peripheral lymphoid organ development require both surface LT-αβ and TNF interacting with their specific receptors. However, these related cytokines are also capable of signaling distinct developmental events. Splenic MAdCAM-1 expression, follicular dendritic cell localization and normal Peyer's patch development all require both surface LT-αβ and TNF activity. Marginal zone formation and splenic B cell localization primarily require surface LT-αβ-LT-β receptor interactions. Primary follicle formation was dependent upon TNF receptor(s) engagement. Interestingly spleen, lymph nodes and Peyer's patches from TNF receptor p60-Fc-expressing mice all develop different abnormalities, suggesting distinct pathways of development in these lymphoid organs. Thymus development appears to be independent of these signaling pathways. These results demonstrate that TNF and LT are crucial for normal peripheral, but not central lymphoid organ development.
Introduction
Tumor necrosis factor (TNF) and lymphotoxin (LT)-α are two partially homologous cytokines with a variety of physiological effects (1) . Both cytokines are pro-inflammatory, and have been shown to induce the activation of T cells, B cells, macrophages, polymorphonuclear leukocytes and endothelial cells as well as the expression of adhesion molecules. TNF mediates programmed cell death, cytolysis of certain types of tumor cells, and inflammatory effects in malaria, bacterial and parasitic infections and in septic shock. TNF has also been shown to have profound effects on the development of spontaneous autoimmune disease (1) . Recently TNF has been shown to be involved in germinal center (GC) formation and humoral immune responses to T-dependent antigens (2) .
A third member of this cytokine family, termed LT-β, shares 22 January 1998 homology with TNF and LT-α (3). Cell bound and soluble TNF and soluble LT-α self-associate into structurally related homotrimers, both capable of binding either the 60 kDa TNF receptor (TNFRp60) or the 80 kDa TNF receptor (TNFRp80) (4) . LT-β, on the other hand, exists only as a membranebound heterotrimeric complex in association with LT-α, forming either LT-α1β2, or LT-α2β1 (5) . LT-α1β2 is the major cell surface form which binds the LT-β (LT-βR), but not the TNFRp60 or TNFRp80 molecules (6) . Recently, a number of reports have suggested that both TNFRp60 and LT-βR are able to signal crucial events required for normal peripheral lymphoid development and function. Mice made deficient in LT-α expression, by selective gene targeting, develop disorganized splenic architecture, and lack both lymph nodes and Peyer's patches (7, 8) . Moreover, follicular dendritic cells (FDC) and GC are absent in these mice (9, 10) . Since both LT-α3-TNFRs and LT-αβ-LT-βR interactions are lost in LT-α-null mice, the issue of which receptor is crucial for which lymphoid events to occur is still not clear. While lymphoid organogenesis has been reported to require surface LT-αβ expression, FDC and GC development has been reported to require TNF, LT-α and TNFRp60 molecules (2, (9) (10) (11) (12) (13) (14) . However, there have been conflicting reports on the requirement of TNFRp60 engagement for various aspects of lymphoid organ development. Peyer's patch formation has been reported to require LT-α and TNFRp60 expression, suggesting that LT-α3-TNFRp60 interactions are critical for Peyer's patch development (7, 8, 15) . However, mice from our animal colony, originally obtained from Dr J. Peschon (Immunex, Seattle, WA), which have been made double deficient in both TNFRp60 and TNFRp80 expression, develop Peyer's patches, although in reduced numbers and size (R. Ettinger and H. O. McDevitt, unpublished data). Moreover, Peyer's patches are also reduced or absent in mice which express the soluble LT-βR-Fc fusion protein, or in mice which lack LT-β expression (11, 12, 14) . Thus which receptor-ligand interactions are required for normal Peyer's patch development is not clear. Moreover, the requirement for TNF-TNFRp60 interactions in primary follicle formation is also not clear (2, 9, 13, (16) (17) (18) (19) .
In an attempt to clarify 'who does what', we have generated mice which express either a soluble LT-βR-Fc (surface LT-αβ neutralized) or TNFRp60-Fc (TNF and soluble LT-α3 neutralized) transgene product, driven by the cytomegalovirus (CMV) promoter. Unlike mice which have been made deficient in either TNF, LT-α, LT-β or TNFRp60 expression, our mice develop a dose-dependent phenotype, allowing us to address questions not possible to address in genetically targeted mice. We attempted to address the following issues: (i) what mechanisms are involved in primary follicle formation and FDC development; (ii) are interdigitating dendritic cells (IDC) as well as FDC affected by lack of TNF and/or LT activity (iii) as with the spleen, are thymus, lymph nodes and Peyer's patches also affected by lack of TNF activity.
Here we report that loss of primary follicle formation, due to lack of TNF activity, does not appear to be due to a lack of proper B cell migration or a loss of FDC development, but rather TNF and/or soluble LT-α3 neutralization appears to arrest lymphoid organ development early in the neonate. Furthermore, spleen, lymph nodes and Peyer's patches, but not the thymus, were each differentially affected by lack of TNF and/or LT-α3 activity, suggesting distinct pathways of development in these lymphoid organs. In addition, while both B cells and FDC were affected in mice which expressed either the TNFRp60-Fc or the LT-βR-Fc fusion protein, T cell and IDC development/localization were unaffected by cytokine neutralization. These results demonstrate that both TNF and surface LT-αβ signal crucial events in peripheral (spleen, lymph nodes and Peyer's patches), but not central (thymic) lymphoid development.
Methods

Plasmid construction
The LT-βR-Fc chimeric construct has previously been described (11) . The vector used to express mTNFRp60-Fc in transgenic mice was constructed from a 0.67 kb NotI-SalI extracellular TNFRp60 fragment (20) and a 0.69 kb SalI-NotI human IgG4 Fc fragment (kindly provided by Dr E. Garber, Biogen, Cambridge, MA). The two DNA fragments were then ligated into the NotI site of the CA116 vector containing the human CMV promoter (-553 to ϩ71) (CA116, a smaller derivative of SAB132, was provided by Dr C. Ambrose) (21) . The CMV-TNFRp60-Fc transgene was then isolated as an EcoRI-HindIII fragment and purified with a QIAquick gel extraction kit (Qiagen, Carpinteria, CA) following the manufacturer's instructions.
Transgenic mouse production and detection Between 2 and 10 ng/µl of the purified CMV-TNFRp60-Fc transgene was microinjected into BALB/c-fertilized oocytes from FVB mice and implanted into pseudopregnant (BALB/cϫ129)F 1 mice in our transgenic mouse production facility. Mice expressing the LT-βR-Fc fusion protein have previously been described (11) . All mice were bred and maintained at the Stanford University Animal Facility under barrier isolation conditions. Genomic DNA was isolated from mouse tails biopsied at 3 weeks of age and offspring containing the integrated transgene were identified by Southern blot analysis using PstI-digested genomic DNA. Soluble chimeric protein in the sera was quantitated by ELISA: 96-well polyvinyl microtiter plates were coated with 1 µg/ml of purified goat anti-human antibody (Sigma, St Louis, MO), the sera were then titered onto the treated plates and detected with alkaline phosphatase-conjugated goat anti-human Fc polyclonal antibody (Caltag, San Francisco, CA) and substrate (PNPP in DEA buffer). Optical density was determined at 420 nM. Transgene-positive mice were then crossed to BALB/c mice to establish founder lines.
Immunohistology
All mice were weighed and spleen, lymph nodes (brachial, axillary and popliteal), Peyer's patches and thymi removed from age-and sex-matched transgenic-positive and -negative littermates. The thymi and spleens were weighed and small intestine Peyer's patches were counted and the serosal surface area determined. Lymphoid organs were either: made into a single-cell suspension and stained for T cell, B cell and macrophage cell surface antigens (see below); fixed in formalin, embedded in paraffin, sectioned and stained with H & E; or embedded in OCT compound, frozen in liquid nitrogen and sectioned for immunohistology. Frozen tissue sections were immediately fixed in acetone for 5 s, and stained as described previously (22) with rat antibodies specific for CD4 T cells (MT4), CD8 T cells (Lyt2), IDC (NLDC145 and hamster A6N418) (23, 24) , B cells (B220: RA3-6B2), FDC (CR-1) (PharMingen, San Diego, CA) and FDC-M1 and FDC-M2 (25) , marginal zone macrophages (ER-TR9) (26) , marginal zone metallophilic macrophages (MOMA-1) (27), MAdCAM-1 vascular addressin (MECA367) (28) or reticular fibroblasts (ER-TR7) (29) . The antibodies were detected with anti-rat Ig-conjugated with horseradish peroxidase (HRP; Dako, Chatsworth, CA), followed by incubation with 3,3Ј-diaminobenzidine tetrahydrochloride (DAB; Sigma). In data not shown, thymi were stained with rat antibodies specific for T cells (KT3, MT4 and Lyt2), B cells (B220: RA3- (29, 30) . Frozen splenic tissue sections were also double-stained in a five-step protocol with either: biotinylated anti-CD4 and streptavidin-conjugated HRP followed by blocking with 5% normal rat sera (NRS) and incubation with rat anti-B220 (RA3-6B2) and anti-rat alkaline phosphatase-conjugated antibody (Jackson Immuno Research, West Grove, PA); biotinylated anti-IgM and streptavidin-conjugated HRP followed by 5% NRS block, and then incubation with rat anti-IgD and antirat alkaline phosphatase-conjugated antibody; biotinylated anti-IgM and streptavidin-conjugated alkaline phosphatase, followed by 5% NRS block and incubation with rat anti-metallophilic macrophages (MOMA-1) and anti-rat HRP-conjugated antibody (Jackson); or rat anti-FDC (FDC-M2) and hamster anti-IDC (N418) followed by incubation with anti-rat alkaline phosphatase-conjugated antibody and antihamster HRP-conjugated antibody (Jackson). Peroxidase activity was detected by incubation for 3-10 min with 0.2 mg/ml DAB containing 0.01% H 2 O 2 in 0.05 M Tris-HCl buffer, pH 7.4. Alkaline phosphatase activity was visualized with 0.1 mg/ml naphthol AS-MX phosphoric acid (Sigma), 0.6 mg/ml Fast blue BB base (Sigma) and 0.1 mg/ml levamizole in 0.1 M Tris-HCl buffer, pH 8.5, at 37°C for 10 min.
Flow cytometry
Single-cell suspensions were prepared from thymus, spleen, lymph nodes and Peyer's patches of 6-week-old transgenicpositive and non-transgenic littermates. Cells (10 6 ) were stained for 30 min with either phycoerythrin (PE)-conjugated anti-CD4 mAb (Caltag) and FITC-conjugated anti-CD8 mAb (Caltag), PE-conjugated anti-B220 (PharMingen), FITC-conjugated anti-CD3ε (PharMingen) or biotinylated anti-MAC-1 (CD11b; Caltag) followed by streptavidin-conjugated PE. The cells were fixed in 1% paraformyhyde and analyzed on a FACScan flow cytometer (Becton Dickinson).
Results
Generation of mice which express a TNFRp60-Fc fusion protein
To examine the role of TNFR in normal lymphoid development, we neutralized TNF and LT-α3 activity in vivo by generating mice which constitutively expressed a soluble murine TNFRp60-human IgG4 (Fc) transgene driven by the CMV promoter. Human IgG4 was specifically chosen since this isotype has been shown to fix complement poorly and lacks Fc receptor binding. The TNFRp60-Fc chimeric construct was put under the control of the CMV promoter to achieve systemic expression of the soluble fusion protein in many tissues (31) .
The purified TNFRp60-Fc fusion construct was microinjected into BALB/c-fertilized oocytes from FVB mice. Mice with an integrated transgene were identified by Southern blot analysis. Soluble chimeric protein activity in the sera was quantitated by ELISA. Three separate founder lines expressing high (~20-40 µg/ml), intermediate (~8 µg/ml) and low (~65 ng/ml) circulating levels of the fusion protein in the sera were established. However, offspring derived from the same founder were found to have large variations in the levels of circulating TNFRp60-Fc fusion protein expression. In data not shown, the bioactivity and specificity of the soluble TNFRp60-Fc chimeric protein was determined by the ability of sera isolated from transgene-positive, but not transgenenegative mice, to inhibit LT-α3-and TNF-but not LT-αβ-mediated killing of WEHI-164 cells, as described previously (32) . Mice expressing the soluble LT-βR-Fc fusion protein, driven by the CMV promoter, have been described (11) . In this study, the soluble LT-βR-Fc chimeric protein was found to specifically neutralize LT-αβ, but not TNF or LT-α activity. Interestingly, the CMV promoter was shown not to drive detectable circulating LT-βR-Fc fusion protein levels until 3 days after birth; newborn pups had undetectable fusion protein in their sera.
Characterization of TNFRp60-Fc mice Spleens, lymph nodes, Peyer's patches and thymi were excised from age-and sex-matched transgene-positive and -negative mice, weighed, and phenotypically characterized with respect to the percentage of cells which expressed T cell and B cell surface antigens as determined by flow cytometry (Table 1 ). Both the thymus and lymph nodes were found to be unaffected by the TNFRp60-Fc fusion protein; no difference was observed in size or cellular composition of these lymphoid organs. Peyer's patch serosal surface area was slightly reduced in mice which expressed the TNFRp60-Fc transgene product compared with the non-transgenic littermates (Table 1) . Moreover, a slight reduction in the percentage cells which expressed B220 and an increase in cells which expressed CD4 was found in Peyer's patches from these mice. Similarly, spleens isolated from TNFRp60-Fc-expressing mice also demonstrated a decrease in B220-expressing cells and a slight increase in CD4-expressing cells. However, no difference in spleen weight was observed in these mice (Table 1) .
'Extended' marginal zones in mice which expressed the TNFRp60-Fc transgene product Upon histologic and immunohistologic analyses, dosedependent phenotypic immunological abnormalities were observed in mice which expressed the TNFRp60-Fc fusion protein.
H & E-stained splenic tissue sections from mice which expressed high and intermediate levels of the TNFRp60-Fc fusion protein showed the marginal zone to be strikingly enlarged (Fig. 1B) . Instead of the well-defined marginal zone (approximately four cell layers deep) seen in the non-transgenic littermates (Fig. 1A and C) , the marginal zone in the TNFR-p60-expressing mice was extended, comprised of many cell layers of what appeared to be large, lightly hematoxylin-stained (or activated) lymphocytes with large nuclei and open chromatin as shown under high magnification (Fig. 1D) .
The splenic marginal zone surrounds the white pulp and separates it from the red pulp. It is composed of a network of reticular cells, predominantly containing marginal zone ER-TR9 ϩ macrophages and resident IgM ϩ IgD -B lymphocytes which surround MAdCAM-1 ϩ endothelial cells lining the marginal sinus and marginal zone MOMA-1 ϩ metallophilic macrophages expressed on the inner sinus of the marginal zone (33) . To determine what cell populations were present in the 'extended' marginal zone in spleens isolated from TNFRp60-Fc-expressing mice, frozen tissue sections were stained with rat antibodies specific for either metallophilic macrophages (MOMA-1), marginal zone macrophages (ER-TR9), reticular fibroblasts (ER-TR7) or MAdCAM-1 on marginal sinus endothelial cells (MECA-367). Unlike spleens isolated from the LT-βR-Fc-expressing mice, MOMA-1-and ER-TR9-expressing macrophages were present in the marginal zones of mice which expressed the TNFRp60-Fc transgene (Figs 2A-F and 3E and F). However, MAdCAM-1 expression was reduced or completely absent (depending on circulating fusion protein levels) in the splenic marginal zones of both LT-βR-Fc-and TNFRp60-Fc-expressing mice (11; compare Fig. 2E and F) . Furthermore, the ER-TR7-expressing reticular fibroblasts did not segregate into distinct T cell and B cell areas in mice which expressed the TNFRp60-Fc transgene product, compared with the non-transgenic littermates (compare Fig. 2A  and B) .
To further elucidate what other cell types were present in this 'extended' marginal zone from TNFRp60-Fc-expressing mice, frozen splenic tissue sections were double-stained with antibodies specific for T cell and B cell surface antigens. As shown in Fig. 3(B) , these 'marginal zone' cells appear to predominantly express B220, forming a band of cells around the CD4-staining T cell periarteriolar lymphoid sheath (PALS). This was in contrast to the polarized B cell follicles observed in the non-transgenic littermates (Fig. 3A) . Splenic tissue sections were also stained with antibodies specific for either IgM or IgD. As shown in Fig. 3(C) , the marginal zone B cells from the non-transgenic control mice expressed IgM, but lacked IgD, whereas the follicular B cell population expressed both IgM and IgD. Interestingly, both population of B cells were present in spleens from mice which expressed the soluble TNFRp60-Fc chimeric protein. However, the IgM low IgD ϩ 'follicular' B cells did not form polarized follicles, but rather formed a concentric band of cells inside of the IgM high IgD -marginal zone B cells in spleens from these mice (Fig. 3D) .
To determine the exact location of the marginal zone and to determine whether the lack of follicle formation was due to an inability of the IgM low IgD ϩ 'follicular' B cells to migrate through the marginal zone, frozen splenic tissue sections were double-stained with MOMA-1 and anti-IgM. MOMA-1 is expressed on metallophilic macrophages which line the inner sinus of the marginal zone. As observed in non-transgenic littermates, MOMA-1 separated the marginal zone IgM high B cells from the 'follicular' IgM low B cells (Fig. 3E) . Likewise, in spleens from mice which expressed the TNFRp60-Fc chimeric protein, the IgM high B cells were separated from the IgM low B cells by MOMA-1 (Fig. 3F) . These data indicate that the 'follicular' IgM low IgD ϩ B cells in TNFRp60-Fc-expressing mice migrated into the peripheral PALS, but were unable to form primary follicles.
FDC have been reported to be absent in TNF-, TNFRp60-and LT-α-null mice. FDC normally form as networks, located in the B cell primary follicle (Fig. 3G) . In spleens isolated from mice that expressed high levels of the TNFRp60-Fc transgene product, a total absence of FDC expression was observed as determined with several FDC-specific antibodies (data not shown). However, in mice which expressed intermediate levels of the transgene product, the splenic FDC were present, but reduced, did not form networks and co-localized with the B cells in the absence of primary follicle formation, as determined with CR-1, FDC-M1 and FDC-M2 reactivity (Fig.  3H and data not shown) . Interestingly, IDC appeared to be unaffected in their presence and distribution by the lack of TNF and/or LT-α3 activity in these mice, as determined with both N418 and NLDC145 antibodies (Fig. 3H and data not shown).
Surface LT-αβ is required for the presence of FDC but not IDC in the spleen
To further extend our analysis of mice expressing the LT-βR-Fc chimeric fusion protein, frozen splenic tissue sections were stained with specific antibodies for IDC and FDC surface antigens. As shown in Fig. 4 and as reported previously, splenic B cells were found to localize within the T cell areas in mice that expressed the LT-βR-Fc fusion protein (Fig. 4B and F) (11) . Moreover, the majority of the B cells were located at the perimeter of the T cell zone and appeared unable to enter into the peripheral PALS where primary follicle formation normally occurs. This was in striking contrast to the non-transgenic littermates in which good segregation between the T cell PALS and B cell follicles was observed ( Fig. 4A and E) . In spleens isolated from both LT-βR-Fc-expressing mice and non-transgenic littermates, IDC correctly localized around the central arterioles in the inner PALS, as determined with both N418 and NLDC145 antibodies (compare Fig. 4C and D, and data not shown). However, splenic FDC were absent or reduced (depending on circulating LT-βR-Fc concentration in the sera) in mice in which surface LT-αβ had been neutralized by the circulating transgene product (compare Fig. 4G and H) .
Lack of primary follicles and displaced FDC localization in lymph nodes from mice expressing the TNFRp60-Fc chimeric protein
To determine if the lack of primary follicle formation was specific for the spleen, or extended to the lymph nodes, brachial, axillary and popliteal lymph nodes were excised from either the TNFRp60-Fc-expressing mice or the transgene-negative littermates. Primary follicles appeared to be absent in H & E-stained tissue sections from lymph nodes of mice which expressed the TNFRp60-Fc fusion protein (compare Fig. 1E and F) . Frozen tissue sections of lymph nodes were stained with antibodies specific for B cell, T cell, IDC, FDC and macrophage surface antigens (Fig. 5A-J) . As in the spleen, T cells and IDC appeared normal in their presence and distribution, located in the paracortex of lymph nodes from both the TNFRp60-Fc-expressing mice and the non-transgenic littermates (Fig. 5A-D) . In control mice, the B cells formed primary follicles in which FDC networks were observed (Fig. 5E and G) . However, in lymph nodes isolated from mice which expressed the TNFRp60-Fc fusion protein (or from TNFRp60/p80-mutant mice), the B cells did not form primary follicles, but rather accumulated as a concentric band of cells in the outer cortex ( Fig. 5F and data not shown) . Moreover, FDC-M2-reactive cells were present, did not form networks, but rather localized just under the subcapsular sinus in lymph nodes from mice which expressed intermediate levels of the TNFRp60-Fc fusion protein (Fig. 5H) . No staining in this region was observed with FDC-M2 in lymph nodes isolated from control mice (Fig. 5G ) nor was staining detected under the subcapsular sinus of lymph nodes from the TNFRp60-Fcexpressing mice when stained with control antibody (data not shown). The FDC-M2-expressing cells appeared to co-localize with the MOMA-1-expressing macrophages, which normally persist in the subcapsular sinus of normal mice (Fig. 5I-J) . However, no staining was observed with CR-1 antibody and little or no reactivity was found with the FDC-M1 antibody in lymph nodes isolated from these mice (data not shown). Interestingly, we observed no or little staining with any of the FDC-reactive antibodies in lymph nodes isolated from mice which expressed high levels of the TNFRp60-Fc fusion protein.
Lack of T cell organization in Peyer' s patches from TNFRp60-Fc-expressing mice Peyer's patches consist mostly of large B cell follicles and small T cell areas which form on the outside of the follicles, as shown with B220 and CD4 reactivity in control mice (Fig. 6A  and C) . T cells are also observed in the GC (Fig. 6C) . In normal mice, GC chronically persist in Peyer's patches in the absence of immunization. Peyer's patches isolated from germfree mice lack GC which form following the selective introduction of a single infectious agent (34) . Unlike the spleen and lymph nodes, B cells appeared to correctly localize within Peyer's patches isolated from mice which expressed the TNFRp60-Fc chimeric protein, as demonstrated with B220 expression (Fig. 6B) . However, many CD4-expressing T cells were observed in the B cell areas (Fig. 6D) . Moreover, FDC networks were reduced or absent in TNFRp60-Fc-expressing mice compared with the non-transgenic littermates as determined with both CR-1 and FDC-M1 mAb (compare Fig. 6E -F and data not shown). MAdCAM-1 is normally expressed on FDC in Peyer's patch GC, as well as on high endothelial venules (HEV) (35) (Fig. 6G ). Peyer's patches isolated from mice which produced the TNFRp60-Fc transgene product expressed MAdCAM-1 on the HEV, but not on other cell types (Fig. 6H) . The lack of FDC-M1, CR-1 and MAdCAM-1 expression in the Peyer's patches suggests that FDC were not able to localize/differentiate in the absence of TNF and/ or LT-α3 activity. Interestingly, GC were present in the Peyer's patches of mice that expressed either the TNFRp60-Fc or LT-βR-Fc transgene product, as shown by staining with H & E (Fig. 1 H) (11) . Furthermore, the presence of GC was verified with peanut agglutinin (PNA) and anti-IgD. Serial tissue sections of Peyer's patches isolated from TNFRp60-Fcexpressing mice showed that B220 ϩ , PNA ϩ , IgD -clusters had no or little reactivity with either CR-1 or FDC-M1 antibodies (data not shown). These observations demonstrate that Peyer's patch GC are able to form in the absence of FDC. The ability to form GC in the absence of FDC has also recently been reported in mesenteric lymph nodes (14) .
Thymus development is independent of LT-βR and TNFR interactions
Although very striking, dose-dependent effects of both the LT-βR-Fc and TNFRp60-Fc transgene product were observed in spleen, lymph node and Peyer's patches, no thymic abnormalities were found in all mice examined. In data not shown, frozen thymic tissue sections were stained with rat antibodies specific for T cell, B cell, dendritic cell, cortical epithelium, medullary epithelium and reticular fibroblast surface antigens. No structural difference between the nontransgenic littermates and either the TNFRp60-Fc-expressing or the LT-βR-Fc-expressing mice were detected. Moreover, the ratio of single-positive and double-positive thymocytes was indistinguishable between both transgenic mouse lines and their non-transgenic littermates, indicating normal thymocyte development (data not shown). The ability of thymocytes to properly positively and negatively select in mice expressing either the TNFRp60-Fc and LT-βR-Fc transgene product is currently being evaluated.
Discussion
The results of the present study, in combination with results of our previous studies, demonstrate that LT-βR and TNFR signal distinct events in peripheral, but not central, lymphoid organ development (11) . Our data suggest that surface LT-αβ expression is required for the development of splenic marginal zone cell populations, B cell localization and FDC differentiation/migration. TNF activity appears to be crucial for B cell primary follicle formation, reticular stromal differentiation and FDC development/localization. IDC and T cell development/migration appears to be independent of both these signaling pathways. Interestingly, the peripheral lymphoid organs were all uniquely affected by neutralization of TNF and LT-α3 activity in the TNFRp60-Fc-expressing mice, suggesting distinct pathways of development.
Spleen, lymph nodes and Peyer's patches isolated from mice which expressed the TNFRp60-Fc fusion protein all displayed distinct phenotypic abnormalities. In spleen and lymph nodes, primary follicles did not develop. However, B cell localization was unaffected in Peyer's patches isolated from these mice. Furthermore, T cell localization was disorganized in Peyer's patches isolated from mice which expressed the TNFRp60-Fc fusion protein, which was in direct contrast to the well-segregated T cell and B cell areas in spleen and lymph nodes from these mice. These data suggest that Peyer's patch development is distinct from that of the other peripheral lymphoid organs.
The origin of FDC is controversial. Some studies suggest that FDC develop locally from the surrounding reticular network (36) (37) (38) (39) , other studies suggest that FDC migrate into the peripheral lymphoid organs (40, 41) . Studies from Tew's laboratory suggest that FDC are derived from antigen-transporting cells (ATC) of bone marrow origin (reviewed in 42). They have demonstrated that ATC are monocyte-like cells that transport antigen from the afferent lymph to the lymph node follicles via the subcapsular sinus. During antigen transport, ATC were shown to mature into cells which morphologically resembled FDC. Thus, it was concluded that ATC are FDC precursors (42, 43) . Consistent with the hypothesis that FDC migrate into the lymph node, FDC-specific antibodies have been shown to bind cells located under the subcapsular sinus in rat lymph nodes (44) . However, studies from Dijkstra's laboratory demonstrated that FDC are not of bone marrow origin, but are derived locally in the spleen from the fibroblastic reticulum located in the follicles (36, 38) .
Our study is consistent with results from both Dijkstra's and Tew's laboratories. Whereas FDC in the spleen appeared to develop from the surrounding reticular meshwork, FDC in the lymph node appeared to develop from migrating cells which enter via the subcapsular sinus. Spleens isolated from mice which expressed high concentrations of the TNFRp60-Fc fusion protein, or from mice which have been made deficient for either TNF or TNFRp60 expression do not contain cell populations which react with antibodies specific for FDC (2,10,13). However, in spleens isolated from mice which expressed intermediate levels of the TNFRp60-Fc fusion protein, the FDC were present, but did not form networks, and co-localized with the B cells in the absence of primary follicle formation (Fig. 3H) . Moreover, in these mice, the fibroblastic reticulum did not appear to differentiate into distinct T cell and B cell regions (Fig. 2B ). These observations suggest that TNF is required for primary follicle formation. We suggest that in the spleen, TNF produced by B cells located in the peripheral PALS, activate the surrounding stroma to lose ER-TR7 expression, gain FDC-M1, FDC-M2 and CR-1 expression, and differentiate into FDC. Alternatively, TNF may be inducing other FDC precursors to differentiate into FDC.
Likewise, FDC were not present in lymph nodes from high TNFR p 6D-F c -expressing mice. However, FDC-M2-reactive cells were present in lymph nodes isolated from mice expressing intermediate concentrations of the TNFRp60-Fc fusion protein. In these mice, the FDC did not form networks, but rather were displaced under the subcapsular sinus, colocalizing with the MOMA-1-expressing cells, and appeared unable either to differentiate or migrate into the B cell-rich outer cortex (Fig. 5H and J) . The possibility that the FDC-M2 expressing cells in the subcapsular sinus of lymph nodes isolated from TNFRp60-Fc-expressing mice are early FDC precursors, perhaps of myeloid origin, is presently being evaluated. Together, these data suggest that FDC develop differently in the spleen and lymph nodes, and/or FDC develop from distinct precursor cells in these lymphoid organs.
The mechanism by which B cells form primary follicles is unknown. Van Ewijk and co-workers have demonstrated that B cells (and T cells) enter the spleen through terminal arterioles, which branch from central arterioles. The terminal arterioles open into either the marginal sinus, which is lined with MAdCAM-1, or the marginal zone, a structure which separates the white pulp from the red pulp (see Fig. 7 ) (45) . B cells then first traffic through the T cell areas (inner PALS) before trafficking into the outer PALS, where the primary follicles form as organized nodules, containing predominantly IgM low IgD ϩ small non-cycling B lymphocytes and FDC networks. It is not know what signals B cells to enter into the outer PALS and form polarized follicles. The lack of primary follicle formation in spleens isolated from TNFRp60-Fcexpressing mice was not due to a lack of B cell migration into the white pulp of the spleen caused by the loss of MAdCAM-1 expression on the marginal sinus: marginal zone metallophilic macrophages (MOMA-1 ϩ ) separated the marginal zone B cells from the 'follicular' B cells (Fig. 3F ). These data demonstrate that B cells were migrating into the PALS in the absence of MAdCAM-1 expression. This is consistent with reports from Kraal and co-workers who demonstrated that blockade of MAdCAM-1-α 4 β 7 interactions with specific antibodies did not impair the migration of B cells into follicular regions (46) . The lack of primary follicle formation was also not due to a lack of B cell trafficking to the outer PALS in mice which expressed the TNFRp60-Fc fusion protein, as B cells were found in the peripheral PALS, where primary follicles usually form (Fig 3B) . However, unlike TNFRp60-Fc mice, B cells in spleens isolated from LT-βR-Fc mice failed to traffic to the peripheral PALS (Fig. 4F) . These data suggest that the loss of follicle formation in mice which expressed the LT-βR-Fc fusion protein may be due to a defect in B cell trafficking.
The ability to form primary follicles may involve a mechanism in which molecular cross-talk between B cells, FDC and the surrounding reticulum occurs. This cross-talk between B cells and FDC has been reported by Kosco and co-workers who demonstrated that FDC are required for adhesion and proliferation of B cells in vitro (47) . The clustering of B cells and FDC involves ICAM-1 and VCAM-1 molecules expressed on FDC interacting with LFA-1 and VLA-4 expressed on B cells (48) . Thus, in vivo, this clustering of B cells and FDC presumably induces the formation of a primary follicle. However, reticular fibroblasts also appear to be involved in primary follicle formation. Severe combined immunodeficient (SCID) mice lack functional T cells, B cells and FDC (40, 49) . In these mice, the splenic reticular meshwork is not differentiated. Reconstitution of SCID mice with lymphocytes results in differentiation of the reticulum into phenotypically distinct areas in which primary follicles form and FDC of host origin develop (50, 51) . Both the differentiation of the reticulum and development of the FDC were shown to be B cell-dependent. However, in SCID transfer studies, a combination of both B cells and T cells was reported to be more efficient at inducing FDC development than B cells alone (40) . Thus, both reticular stroma and FDC differentiation were shown to be dependent upon lymphocytes or lymphocyte-derived factors (51) .
This cross-talk phenomenon is presumably missing in mice which expressed the TNFRp60-Fc fusion protein, due to neutralization of TNF and/or LT-α3 activity. The absence of primary follicle formation and FDC migration/differentiation in these mice appeared to be due to a block in communication between the lymphocytes and surrounding stroma. As in SCID mice, the splenic reticular network was not differentiated in TNFRp60-Fc-expressing mice. This network is normally associated with segregation of the PALS and B cell follicles ( Figs 2B and 7D) (50) . Normally, the reticular fibroblast meshwork is not homogenous, but rather the T cell PALS, the B cell follicles and the marginal zone are all phenotypically distinct, as shown with ER-TR7 mAb (Fig. 7D) . No obvious areas which lacked ER-TR7 determinants, as seen in the B cell areas of the control mice ( Fig. 2A) , were observed in the B cell areas from mice which expressed the TNFRp60-Fc fusion protein (Fig. 2B) . These data suggest that the reticular fibroblasts in the TNFRp60-Fc-expressing mice were not forming the correct microenvironment for B cell follicles and/ or FDC to form and/or develop. Alternatively, it has been suggested that GC arise from oligoclonal expansion of B cells in follicular areas, pushing away the reticular fibroblasts to the periphery of the follicles. The lack of ER-TR7 expression in the B cell areas of control mice may reflect the expansion of a well-developed B cell follicle. Thus, the splenic ER-TR7 staining pattern observed in the TNFRp60-Fc-expressing mice may appear more compact due to the lack of primary follicle formation.
The mechanisms involved in lymphoid organogenesis are unclear. However, the phenotype which arises in the peripheral lymphoid organs in mice which expressed the TNFRp60-Fc fusion protein resembled that of neonatal mice. Normally, primary follicles and FDC networks are absent in spleens and lymph nodes of young mice. Early in ontogeny, the spleen becomes populated with B cells, shortly followed by the emergence of T cells and IDC. The entry of the T cells into the white pulp displaces the B cells into the outer PALS, thus forming distinct regions of T cells and B cells (Fig. 7A  and D) . Approximately at day 4-7 (depending on strain backgrounds), B cells in the outer PALS form follicles, which are associated with changes in the reticular stroma, development of bridging channels and emergence of FDC ( Fig. 7B ; R. Mebius, unpublished results). An apparent block in both follicle development and FDC migration/differentiation occur in the TNFRp60-Fc-expressing mice, which appears to result in an arrest of lymphoid organ development (Fig. 7A and B) . Consistent with this, bridging channels were also much less apparent in spleens isolated from mice which expressed the TNFRp60-Fc fusion protein. Mice which have been made genetically deficient in TNF (2) or both TNFRp60 and TNFRp80 expression (R. Ettinger and H. O. McDevitt, unpublished results) developed similar splenic phenotypes to the TNFRp60-Fc-expressing mice, suggesting that TNF, but not LT-α3, is important for primary follicle development and FDC differentiation/migration. Consistent with this, non-obese diabetic mice treated with TN3.19.12 mAb which neutralizes TNF, but not LT-α3 activity, develop similar phenotypes to those seen in mice which express the TNFRp60-Fc fusion protein (R. Ettinger et al., manuscript in preparation). Interestingly, Forster and co-workers have demonstrated that spleens isolated from mice which lack the BLR1 chemokine receptor also do not develop primary follicles, FDC or bridging channels (52) . It is unclear if this chemokine signals TNF production. However, it has recently been suggested by Goodnow and Cyster that BLR1 signals B cells to produce TNF (53) .
A different mechanism appears to affect splenic development in mice which expressed the LT-βR-Fc chimeric protein. Unlike the extended marginal zone which developed in mice which expressed the TNFRp60-Fc fusion protein, mice which expressed high concentrations of the LT-βR-Fc chimeric protein lack splenic marginal zone formation. Several cell populations which normally make up the marginal zone were missing. The lack of the marginal zone in the LT-βR-Fc expressing mice resulted in a loss of segregation between the red pulp and the white pulp of the spleen. T cells and B cells did not segregate into distinct areas, but rather T cells, B cells and IDC were all located in the inner PALS, which notably lacked FDC networks and follicles (Fig. 7C ). Mice which have been made genetically deficient in either LT-α (7, 8) or LT-β (14) expression by selected gene targeting also develop similar phenotypes. These data suggest that surface LT-αβ is required for marginal zone formation, B cell localization to the outer PALS and FDC differentiation/migration. These processes may be independent of one another. However, the loss of the splenic marginal zone may be the pivotal defect in mice which express the LT-βR-Fc fusion protein. Consistent with this hypothesis, marginal zone B cells have been reported to be required for FDC development (54, 55) . Thus, the inability of B cells to properly migrate to the outer PALS and form follicles, as well as the loss of the FDC population, may be secondary to the loss of the splenic marginal zone.
In summary, our data suggest that some aspects of peripheral, but not central, lymphoid organ development require both surface LT-αβ and TNF interacting with their specific receptor(s). However, TNF and LT-αβ are also capable of signaling distinct developmental events. Both surface LT-αβ and TNF appear to be required for normal Peyer's patch development, FDC migration/differentiation and marginal zone MAdCAM-1 expression. Surface LT-αβ is also essential for splenic marginal zone formation and B cell localization to the outer PALS. TNF is required for primary follicle formation. However, B cells are able to migrate to the peripheral PALS in the absence of TNF activity. T cell localization and IDC development appear to be independent of TNF and LT-αβ interacting with their specific receptor(s). The selective expression of LT-βR and TNFRs and their ligands on specific cell populations may be vital in fully understanding the underlying mechanisms involved in lymphoid development and maturation.
